Document Detail

Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
MedLine Citation:
PMID:  23002158     Owner:  NLM     Status:  Publisher    
The expected duration of initial antiparkinson monotherapy before the need for supplementation is not clearly defined for routine practice. The aim of this study was to define the length of l-dopa (L-3, 4-dihydrophenylalanine) and dopamine agonist monotherapy. The duration of monotherapy and discontinuation rates were investigated in a natural observational setting by plotting Kaplan-Meier survival curves. Out of 345 patients, 180 (52.2%) received l-dopa and 165 (47.8%) received a dopamine agonist as initial monotherapy. Half of the patients starting l-dopa received supplementary therapy with- in 3.6 years (95% confidence interval, 3.2-4.6), significantly longer than for dopamine agonist monotherapy (half required a second agent at 2.3 years [2.0-2.9]; P = 0.00017). Discontinuation of l-dopa therapy was 1%. Dopamine agonists were stopped (due to side-effects like impulse control disorders [6%], somnolence [4%] and light-headedness [3%]) in 20% over four years. The duration and tolerability of l-dopa and dopamine agonists as initial Parkinson's disease monotherapy are defined in this study; this may form part of the information exchange with patients.
T Nissen; E J Newman; K A Grosset; M Daghem; G Pal; M Stewart; P Odin; G J Macphee; D G Grosset
Related Documents :
24404968 - Analysis of complications in 430 consecutive pediatric patients treated with intratheca...
25066648 - Complex decongestive therapy and taping for patients with postmastectomy lymphedema: a ...
24418368 - Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis r...
20304278 - Triverse versus molecular resonance-harvested grafts in single-stage baha surgery.
20060628 - Stability and variability of knee kinematics during gait in knee osteoarthritis before ...
19220538 - Stroke discharges from a rehabilitation unit - 1 and 5 year domicile outcomes: function...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-21
Journal Detail:
Title:  Scottish medical journal     Volume:  -     ISSN:  0036-9330     ISO Abbreviation:  Scott Med J     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2983335R     Medline TA:  Scott Med J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Neurology, Klinikum Bremerhaven, Bremerhaven, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Estimating the potential of tissue donation in Scotland.
Next Document:  Anabolic steroids in patients undergoing total knee arthroplasty.